Neggy Rismanchi, M.D., Ph.D.
Associate Clinical Professor, Department of Neurology
Director, UC Davis Pediatric Intractable Epilepsy Clinic
To see if Neggy Rismanchi is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
UC Davis Midtown Ambulatory Care Center
Midtown Neurology Clinic
3160 Folsom Blvd
Sacramento, CA 95816
Phone: 916-734-3588
Philosophy of Care
I strive to obtain a comprehensive understanding of my patient’s medical history, neurologic condition, and familial goals of care. My goal is to share my knowledge with families on neurophysiology, current evidence-based practices, and applicable research findings so that together, we can create a treatment plan specific for their child. Continued healthy dialogue and open communication between appointments are critical in ensuring that issues are addressed or changes made promptly to optimize overall health outcomes and quality of life for my patients and their caretakers.
Clinical Interests
Dr. Neggy Rismanchi is an associate professor of pediatric neurology with specialized training in pediatric epilepsy. She has bachelor of science degrees in psychology as well as neurobiology, physiology, and behavior from UC Davis, obtained a doctor of medicine (MD) and a doctor of philosophy (PhD) degree in neuroscience from Pennsylvania State University through the Graduate Partnership Program (GPP) at the National Institutes of Health (NIH), completed her child neurology residency training at UC San Diego, and her epilepsy fellowship at UC Irvine- Children’s Hospital of Orange County (CHOC). Dr. Rismanchi is the director of the Pediatric Intractable Epilepsy Clinic at UC Davis which is focused on the evaluation and treatment of medication-resistant epilepsy, including surgical and non-surgical options.
Research/Academic Interests
Dr. Rismanchi’s research interests include understanding and the management of various forms of epilepsies, with a particular interest in neuromodulation. She is also interested in how neuromodulation, such as transcranial magnetic stimulation (TMS), can be utilized as a therapeutic intervention for various neurologic or mental health conditions.
Division
Pediatric Neurology
Center/Program Affiliation
UC Davis Medical Group
Neurosciences Center
Undergraduate School
B.S., Neurobiology, Physiology and Behavior, University of California, Davis, Davis CA 2001
Undergraduate School
B.S., Psychobiology, University of California, Davis, Davis CA 2001
Medical School
M.D., Pennsylvania State University, Hershey PA 2010
Other School
Ph.D., Neuroscience, Pennsylvania State University, Graduate Partnership Program with National Institutes of Health, Washington D.C. and Hershey PA 2008
Internship
Pediatrics, Children's Hospital of Orange County, Orange CA 2010-2012
Residency
Pediatric Neurology, UC San Diego, Rady Children's Hospital, San Diego CA 2012-2015
Fellowship
Clinical Epilepsy, University of California, Irvine, Children's Hospital of Orange County, Irvine CA 2015-2016
Fellowship
Epilepsy Research, University of California, Irvine, Irvine CA 2016-2017
Macdonald-Laurs E, Sharpe CS, Nespeca M, Rismanchi N, Gold JJ, Kuperman R, Wang S, Lee M, Michelson DJ, Haas RH, Reed P, Davis SL. Does the first hour of continuous electroencephalography predict neonatal seizures? Arch Dis Child Fetal Neonatal Ed. 2021 Mar;106(2):162-167. doi: 10.1136/archdischild-2020-318985. Epub 2020 Sep 14. PMID: 32928896.
Sharpe C, Reiner GE, Davis SL, Nespeca M, Gold JJ, Rasmussen M, Kuperman R, Harbert MJ, Michelson D, Joe P, Wang S, Rismanchi N, Le NM, Mower A, Kim J, Battin MR, Lane B, Honold J, Knodel E, Arnell K, Bridge R, Lee L, Ernstrom K, Raman R, Haas RH. NEOLEV2 INVESTIGATORS. Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial. Pediatrics. 2020 Jun;145(6):e20193182. doi: 10.1542/peds.2019-3182. Epub 2020 May 8.
Rismanchi N, Gold JJ, Sattar S, Glaser CA, Sheriff H, Proudfoot J, Mower A, Nespeca M, Crawford JR, Wang SG. Neurological Outcomes after presumed childhood encephalitis. Pediatr Neurology. 53(3):200-206, 2015
Rismanchi N, Gold JJ, Sattar S, Glaser CA, Sheriff H, Proudfoot J, Mower A, Crawford JR, Nespeca M, and Wang SG. Epilepsy after resolution of presumed childhood encephalitis. Pediatr Neurology. 2015; 53(1):65-72.
Hu J, Yoko S, Zhu PP, Voss C, Rismanchi N, Prinz WA, Rapoport TA, Blackstone C. A class of dynamin-like GTPases involved in the generation of the tubular ER network. Cell. 2009; 138(3): 549-61.
Rismanchi N, Puertollano R, and Blackstone C. STAM Adaptor Proteins Interact with COPII Complexes and Function in ER-to-Golgi Trafficking. Traffic. 2009; 102): 201-217.
Yang D, Rismanchi N, Renvoise B, Lippincott-Schwartz J, Blackstone C, Hurley JH. Spastin and ESCRT-III coordinate midbody resolution at the final stage of cytokinesis. Nature Structural & Molecular Biology. 2008: 15: 1278-86.
Rismanchi N, Soderblom C, Stadler J, Zhu PP, Blackstone C. Atlastin GTPases are required for Golgi apparatus and ER morphogenesis. Human Molecular Genetics. 2008; 17 (11): 1591-1604.
Arnoult D, Rismanchi N, Grodet A, Roberts RG, Seeburg DP, Estaquier J, Sheng M, and Blackstone C. Bax/Bak- dependent release of DDP/TIMM8a promotes Drp1-mediated mitochondrial fission and mitoptosis during programmed cell death. Current Biology. 2005; 15: 2112-2118.
Rismanchi N, Floyd CL, Berman RF, Lyeth BG. Cell death and long-term maintenance of neuron-like state after differentiation of rat bone marrow stromal cells: a comparison of protocols. Brain Research. 2003; 991:46-55.